MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/nu17010072

Медицинская библиотека · Nutrients · 2024

Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity.

Maqoud Fatima, Calabrese Francesco Maria, Celano Giuseppe, Mallardi Domenica, Goscilo Francesco, D'Attoma Benedetta, Ignazzi Antonia, Linsalata Michele, Bitetto Gabriele, Di Chito Martina, Pesole Pasqua Letizia, Diciolla Arianna, Apa Carmen Aurora, De Pergola Giovanni, Giannelli Gianluigi, De Angelis Maria, Russo Francesco

СтатьяПеревод в очереди

Аннотация

AIMS: This study explores the link between body mass index (BMI), intestinal permeability, and associated changes in anthropometric and impedance parameters, lipid profiles, inflammatory markers, fecal metabolites, and gut microbiota taxa composition in participants having excessive body mass.

METHODS

A cohort of 58 obese individuals with comparable diet, age, and height was divided into three groups based on a priori clustering analyses that fit with BMI class ranges: Group I (25-29.9), Group II (30-39.9), and Group III (>40). Anthropometric and clinical parameters were assessed, including plasma C-reactive protein and cytokine profiles as inflammation markers. Intestinal permeability was measured using a multisaccharide assay, with fecal/serum zonulin and serum claudin-5 and claudin-15 levels. Fecal microbiota composition and metabolomic profiles were analyzed using a phylogenetic microarray and GC-MS techniques.

RESULTS

The statistical analyses of the clinical parameters were based on the full sample set, whereas a subset composed of 37 randomized patients was inspected for the GC/MS metabolite profiling of fecal specimens. An increase in potentially pro-inflammatory bacterial genera (e.g., Slackia, Dorea, Granulicatella) and a reduction in beneficial genera (e.g., Adlercreutzia, Clostridia UCG-014, Roseburia) were measured. The gas chromatography/mass spectrometry analysis of urine samples evidenced a statistically significant increase in m-cymen-8-ol, 1,3,5-Undecatriene, (E, Z) and a decreased concentration of p-cresol, carvone, p-cresol, and nonane.

CONCLUSIONS

Together, these data demonstrated how an increased BMI led to significant changes in inflammatory markers, intestinal barrier metabolites, glucose metabolism, endocrine indicators, and fecal metabolomic profiles that can indicate a different metabolite production from gut microbiota. Our findings suggest that targeting intestinal permeability may offer a therapeutic approach to prevent and manage obesity and related metabolic complications, reinforcing the link between gut barrier function and obesity.

Для цитирования: Maqoud Fatima, Calabrese Francesco Maria, Celano Giuseppe, Mallardi Domenica, Goscilo Francesco, D'Attoma Benedetta, Ignazzi Antonia, Linsalata Michele, Bitetto Gabriele, Di Chito Martina, Pesole Pasqua Letizia, Diciolla Arianna, Apa Carmen Aurora, De Pergola Giovanni, Giannelli Gianluigi, De Angelis Maria, Russo Francesco. Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity.. Nutrients. 2024. DOI: 10.3390/nu17010072.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.